ENTPD1 and ovarian carcinoma: CD39 has been observed to be highly expressed in different human tumor types, such as renal cell carcinoma, ovarian cancer, sarcoma cancer, breast cancer, lymphoma, bladder cancer, colon cancer and melanoma [19,20,21,22].